Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly von Omuro, Antonio M P, Taillandier, Luc, Chinot, Olivier, Carnin, Charlotte, Barrie, Maryline, Hoang-Xuan, Khe

Volltext

Lessons learned in the development of targeted therapy for malignant gliomas von Omuro, Antonio M P, Faivre, Sandrine, Raymond, Eric

Volltext

Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited von Gupta, Ajay, Omuro, Antonio M. P., Shah, Akash D., Graber, Jerome J., Shi, Weiji, Zhang, Zhigang, Young, Robert J.

Volltext

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib von Omuro, Antonio M. P., Kris, Mark G., Miller, Vincent A., Franceschi, Enrico, Shah, Neelam, Milton, Daniel T., Abrey, Lauren E.

Volltext

Pitfalls in the diagnosis of brain tumours von Omuro, Antonio MP, Leite, Claudia C, Mokhtari, Karima, Delattre, Jean-Yves

Volltext

Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant von Therkelsen, Kate Elizabeth, Schaff, Lauren R, Nandakumar, Subhiksha, Omuro, Antonio M P, DeAngelis, Lisa M, Grommes, Christian

Volltext

Salvage temozolomide for prior temozolomide responders von Franceschi, Enrico, Omuro, Antonio M. P., Lassman, Andrew B., Demopoulos, Alexis, Nolan, Craig, Abrey, Lauren E.

Volltext

What is the relevance of determining EGFR-variant-III status in glioblastomas? von Omuro, Antonio MP

Volltext

Chemotherapy for primary central nervous system lymphoma von Omuro, Antonio M P, Abrey, Lauren E

Volltext

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis von OMURO, Antonio M. P, LALLANA, Enrico C, BILSKY, Mark H, DEANGELIS, Lisa M

Volltext

Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-up von OMURO, Antonio M. P, DEANGELIS, Lisa M, YAHALOM, Joachim, ABREY, Lauren E

Volltext

Long-term Outcomes in Primary CNS Lymphoma Following R-MVP and High Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant von Therkelsen, Kate Elizabeth, Schaff, Lauren R, Nandakumar, Subhiksha, Omuro, Antonio M. P., DeAngelis, Lisa M., Grommes, Christian

Volltext

Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma? von Omuro, Antonio MP

Volltext

Hypersexuality following bilateral thalamic infarction: case report von Mutarelli, Eduardo G, Omuro, Antonio M P, Adoni, Tarso

Volltext

Effect of Carboxyamidotriazole Orotate, a Modulator of Calcium-Dependent Signaling Pathways, on Advanced Solid Tumors von Taylor, Matthew H., Sandler, Alan, Urba, Walter J., Omuro, Antonio M. P., Gorman, Greg S., Karmali, Rashida A.

Volltext

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma von Kaley, Thomas J, Wen, Patrick, Schiff, David, Ligon, Keith, Haidar, Sam, Karimi, Sasan, Lassman, Andrew B, Nolan, Craig P, DeAngelis, Lisa M, Gavrilovic, Igor, Norden, Andrew, Drappatz, Jan, Lee, Eudocia Quant, Purow, Benjamin, Plotkin, Scott R, Batchelor, Tracy, Abrey, Lauren E, Omuro, Antonio

Volltext

In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine von Dunphy, Mark P S, Harding, James J, Venneti, Sriram, Zhang, Hanwen, Burnazi, Eva M, Bromberg, Jacqueline, Omuro, Antonio M, Hsieh, James J, Mellinghoff, Ingo K, Staton, Kevin, Pressl, Christina, Beattie, Bradley J, Zanzonico, Pat B, Gerecitano, John F, Kelsen, David P, Weber, Wolfgang, Lyashchenko, Serge K, Kung, Hank F, Lewis, Jason S

Volltext

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma von de la Fuente, Macarena I, Young, Robert J, Rubel, Jennifer, Rosenblum, Marc, Tisnado, Jamie, Briggs, Samuel, Arevalo-Perez, Julio, Cross, Justin R, Campos, Carl, Straley, Kimberly, Zhu, Dongwei, Dong, Chuanhui, Thomas, Alissa, Omuro, Antonio A, Nolan, Craig P, Pentsova, Elena, Kaley, Thomas J, Oh, Jung H, Noeske, Ralph, Maher, Elizabeth, Choi, Changho, Gutin, Philip H, Holodny, Andrei I, Yen, Katharine, DeAngelis, Lisa M, Mellinghoff, Ingo K, Thakur, Sunitha B

Volltext

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma von Mellinghoff, Ingo K., van den Bent, Martin J., Blumenthal, Deborah T., Touat, Mehdi, Peters, Katherine B., Clarke, Jennifer, Mendez, Joe, Yust-Katz, Shlomit, Welsh, Liam, Mason, Warren P., Ducray, François, Umemura, Yoshie, Nabors, Burt, Holdhoff, Matthias, Hottinger, Andreas F., Arakawa, Yoshiki, Sepulveda, Juan M., Wick, Wolfgang, Soffietti, Riccardo, Perry, James R., Giglio, Pierre, de la Fuente, Macarena, Maher, Elizabeth A., Schoenfeld, Steven, Zhao, Dan, Pandya, Shuchi S., Steelman, Lori, Hassan, Islam, Wen, Patrick Y., Cloughesy, Timothy F.

Volltext

Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial von Tabouret, Emeline, Houillier, Caroline, Martin-Duverneuil, Nadine, Blonski, Marie, Soussain, Carole, Ghesquières, Herve, Houot, Roch, Larrieu, Delphine, Soubeyran, Pierre, Gressin, Remy, Gyan, Emmanuel, Chinot, Olivier, Taillandier, Luc, Choquet, Sylvain, Alentorn, Agusti, Leclercq, Delphine, Omuro, Antonio, Tanguy, Marie-Laure, Hoang-Xuan, Khe

Volltext